BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31189769)

  • 1. Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1.
    Hozumi K; Fukuoka H; Odake Y; Takeuchi T; Uehara T; Sato T; Inoshita N; Yoshida K; Matsumoto R; Bando H; Hirota Y; Iguchi G; Taniguchi M; Otsuki N; Nishigori C; Kosaki K; Hasegawa T; Ogawa W; Takahashi Y
    Endocr J; 2019 Oct; 66(10):853-857. PubMed ID: 31189769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and Acromegaly.
    Yasuda S; Inoue I; Shimada A
    Intern Med; 2021; 60(15):2451-2459. PubMed ID: 34334593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiated thyroid carcinoma in sporadic and familial presentations of acromegaly: A case series.
    Rogozinski A; Daly AF; Reyes A; Furioso A; Beckers A; Lowenstein A
    Ann Endocrinol (Paris); 2020 Oct; 81(5):482-486. PubMed ID: 32822652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIP mutation identified in a patient with acromegaly caused by pituitary somatotroph adenoma with neuronal choristoma.
    Nishizawa H; Fukuoka H; Iguchi G; Inoshita N; Yamada S; Takahashi Y
    Exp Clin Endocrinol Diabetes; 2013 May; 121(5):295-9. PubMed ID: 23674160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation.
    Syro LV; Sundsbak JL; Scheithauer BW; Toledo RA; Camargo M; Heyer CM; Sekiya T; Uribe H; Escobar JI; Vasquez M; Rotondo F; Toledo SP; Kovacs K; Horvath E; Babovic-Vuksanovic D; Harris PC
    Pituitary; 2012 Sep; 15(3):342-9. PubMed ID: 21744088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically silent somatotroph adenomas are common.
    Wade AN; Baccon J; Grady MS; Judy KD; O'Rourke DM; Snyder PJ
    Eur J Endocrinol; 2011 Jul; 165(1):39-44. PubMed ID: 21493729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
    Nasr C; Mason A; Mayberg M; Staugaitis SM; Asa SL
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4776-80. PubMed ID: 16968791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early surgical intervention for patients with possible clinically silent somatotroph adenoma: a case series.
    Kawaguchi T; Ogawa Y; Tominaga T
    J Med Case Rep; 2019 Mar; 13(1):85. PubMed ID: 30862315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual case of metastatic neuroendocrine tumor.
    Manahan MA; Dackiw AP; Ball DW; Zeiger MA
    Endocr Pract; 2007; 13(1):72-6. PubMed ID: 17360306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome.
    Vortmeyer AO; Gläsker S; Mehta GU; Abu-Asab MS; Smith JH; Zhuang Z; Collins MT; Oldfield EH
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2404-13. PubMed ID: 22564667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
    Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acromegaly without imaging evidence of pituitary adenoma.
    Lonser RR; Kindzelski BA; Mehta GU; Jane JA; Oldfield EH
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4192-6. PubMed ID: 20610592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfunctioning thyroid adenoma concomitant with papillary thyroid carcinoma, follicular thyroid adenoma and primary hyperparathyroidism.
    Sato Y; Sakurai A; Miyamoto T; Hiramatsu K; Katai M; Furihata K; Hashizume K
    Endocr J; 1998 Feb; 45(1):61-7. PubMed ID: 9625447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors.
    Yamato A; Nagano H; Gao Y; Matsuda T; Hashimoto N; Nakayama A; Yamagata K; Yokoyama M; Gong Y; Shi X; Zhahara SN; Kono T; Taki Y; Furuki N; Nishimura M; Horiguchi K; Iwadate Y; Fukuyo M; Rahmutulla B; Kaneda A; Hasegawa Y; Kawashima Y; Ohara O; Ishikawa T; Kawakami E; Nakamura Y; Inoshita N; Yamada S; Fukuhara N; Nishioka H; Tanaka T
    Commun Biol; 2022 Nov; 5(1):1304. PubMed ID: 36435867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between atypical parathyroid adenoma and neurofibromatosis.
    Favere AM; Tsukumo DM; Matos PS; Santos SL; Lalli CA
    Arch Endocrinol Metab; 2015 Oct; 59(5):460-6. PubMed ID: 26421674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary hyperparathyroidism associatiated with aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene.
    Honda M; Tsukada T; Horiuchi T; Tanaka R; Yamaguchi K; Obara T; Miyakawa H; Yamaji T; Ishibashi M
    Intern Med; 2004 Apr; 43(4):310-4. PubMed ID: 15168774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MANAGEMENT OF ENDOCRINE DISEASE: Etiology and outcome of acromegaly in patients with a paradoxical GH response to glucose.
    Hage M; Janot C; Salenave S; Chanson P; Kamenický P
    Eur J Endocrinol; 2021 May; 184(6):R261-R268. PubMed ID: 33830942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acromegaly and non-parathyroid hormone-dependent hypercalcemia: a case report and literature review.
    Shi S; Zhang L; Yu Y; Wang C; Li J
    BMC Endocr Disord; 2021 May; 21(1):90. PubMed ID: 33933067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes.
    Ercolino T; Lai R; Giachè V; Melchionda S; Carella M; Delitala A; Mannelli M; Fanciulli G
    Gene; 2014 Feb; 536(2):332-5. PubMed ID: 24361808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.